ETR:HNLDr Hoenle Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Dr Hoenle AG Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €52.10 +3.60 (+7.42 %) (As of 06/2/2020 05:16 AM ET) Add Compare Share Today's Range€49.40Now: €52.10▼€52.1050-Day Range€33.65MA: €37.62▼€49.0552-Week Range€24.45Now: €52.10▼€61.10Volume11,476 shsAverage VolumeN/AMarket Capitalization$287.17 millionP/E Ratio27.30Dividend Yield2.13%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlines Dr. Hönle AG operates in the UV market worldwide. It operates through three segments: Equipment & Systems, Glass & Lamps, and Adhesives. The Equipment & Systems segment offers UV equipment and systems, LED-UV units, IR units, inert systems, disinfection systems, solar simulation systems and light fixtures, lighting systems, UV measuring technology products, UV-adhesives, and components and replacement parts. This segment also provides hot air systems, and powder spraying and extraction systems for sheet-fed offset printing; UV dryers for Web printing; UV systems with nitrogen inertisation for rotary printing; and drying systems. Its products are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Glass & Lamps segment offers UV low and medium pressure lamps; infrared emitters; electronic power supplies; UV sensors and measuring technology products; UV measuring devices; and submersible and immersion tube systems, as well as accessories. This segment also provides UV bulbs; and quartz glass tubing and rods for the lamp, automotive, semiconductor, and fiber cable industries. The Adhesives segment offers industrial, UV, medical grade, and conductive adhesives; dosing systems; potting and sealing compounds; and UV curing units. Dr. Hönle AG was founded in 1976 and is headquartered in Gräfelfing, Germany.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Dr Hoenle. Previous Next 2.4 Community Rank Outperform VotesDr Hoenle has received 16 “outperform” votes. (Add your “outperform” vote.)Underperform VotesDr Hoenle has received 18 “underperform” votes. (Add your “underperform” vote.)Community SentimentDr Hoenle has received 52.94% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Dr Hoenle and other stocks. Vote “Outperform” if you believe HNL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HNL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipDr Hoenle is a leading dividend payer. It pays a dividend yield of 2.13%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthDr Hoenle does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Dr Hoenle is 42.33 %. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dr Hoenle insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dr Hoenle is 27.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.96.Price to Earnings Ratio vs. SectorThe P/E ratio of Dr Hoenle is 27.30, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 35.62.Price to Book Value per Share RatioDr Hoenle has a P/B Ratio of 3.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.11 out of 5 stars Industry, Sector and Symbol Stock Exchange ETR Industry Electronic Components Sub-IndustryN/A SectorComputer and Technology Current SymbolETR:HNL Previous Symbol CUSIPN/A CIKN/A Webwww.hoenle.de Phone49 89 85608 0Debt Debt-to-Equity Ratio34.22 Current Ratio2.81 Quick Ratio1.16Price-To-Earnings Trailing P/E Ratio27.30 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$103.09 million Price / Sales2.79 Cash Flow€3.60 per share Price / Cash Flow14.47 Book Value€16.95 per share Price / Book3.07Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees638 Outstanding Shares5,511,850Market Cap$287.17 million Next Earnings DateN/A OptionableNot Optionable HNL Rates by TradingView Receive HNL News and Ratings via Email Sign-up to receive the latest news and ratings for HNL and its competitors with MarketBeat's FREE daily newsletter. Dr Hoenle (ETR:HNL) Frequently Asked Questions How has Dr Hoenle's stock been impacted by COVID-19 (Coronavirus)? Dr Hoenle's stock was trading at €34.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HNL stock has increased by 51.5% and is now trading at €52.10. View which stocks have been most impacted by Coronavirus. Has Dr Hoenle been receiving favorable news coverage? News coverage about HNL stock has been trending very positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Dr Hoenle earned a media sentiment score of 3.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutDr Hoenle. Who are some of Dr Hoenle's key competitors? Some companies that are related to Dr Hoenle include Discoverie Group (DSCV), Audinategroupltd (AD8), FW Thorpe (TFW), Strix Group (KETL), Gooch & Housego (GHH), Luceco (LUCE), Legend (LGD), Hammond Power Solutions (HPS.A), Ilika (IKA), Xaar (XAR), Nexoptic Technology (NXO), Novonix (NVX), Espey Mfg. & Electronics (ESP), Excelsior Capital (ECL) and RedFlow (RFX). View all competitors. Who are Dr Hoenle's key executives? Dr Hoenle's management team includes the following people: Dr. Norbert Haimerl, CFO, MD, Director of Fin. & HR and Member of Management Board (Age 57)Mr. Heiko Runge, CTO, MD of Sales & Technology and Member of Management Board (Age 55)Peter Weinert, Head of Investor Relations What is Dr Hoenle's stock symbol? Dr Hoenle trades on the ETR under the ticker symbol "HNL." What is Dr Hoenle's stock price today? One share of HNL stock can currently be purchased for approximately €52.10. How big of a company is Dr Hoenle? Dr Hoenle has a market capitalization of $287.17 million and generates $103.09 million in revenue each year. Dr Hoenle employs 638 workers across the globe. What is Dr Hoenle's official website? The official website for Dr Hoenle is www.hoenle.de. How can I contact Dr Hoenle? The company can be reached via phone at 49 89 85608 0. This page was last updated on 6/2/2020 by MarketBeat.com Staff
